1/1
Share:
Cagrilintide
(0)
0 Sold
$100.00
$140.00
What is Cagrilintide
Cagrilintide is a long-acting analog of amylin, developed by Novo Nordisk under the code name AM833. Amylin is a natural hormone: the pancreas releases it alongside insulin after a meal, and it is what tells the brain the meal is over. Natural amylin only lasts a few minutes in the blood. Cagrilintide was redesigned to last about a week — 37 amino acids, a bridge between two cysteines, and a fatty chain that anchors it to blood albumin, the same principle as semaglutide. It is also the "amylin" half of CagriSema, the most studied weight-loss combination since 2024.
Mechanism of action
Cagrilintide binds to amylin and calcitonin receptors, which are highly concentrated in the brain areas that handle satiety. In study models, this reduces food intake and slows gastric emptying: fullness comes on sooner and lasts longer. It is a different pathway from GLP-1s like RETA, tirzepatide, or semaglutide — which is why the two families are studied together rather than against each other. The fatty chain attached to the molecule keeps it circulating bound to blood albumin, extending its half-life to about 7 days and allowing a single weekly administration in study protocols.
1/1


